|
LEVAQUIN ® has been infrequently associated with phototoxicity. You should avoid excessive exposure to sunlight or artificial ultraviolet light while you are taking LEVAQUIN ® . If you have diabetes and you develop a hypoglycemic reaction while on LEVAQUIN ® , you should stop taking LEVAQUIN ® and call your health care professional. Convulsions have been reported in patients receiving quinolone antibiotics including LEVAQUIN ® . If you have experienced convulsions in the past, be sure to let your physician know that you have a history of convulsions. Quinolones, including LEVAQUIN ® , may also cause central nervous system stimulation which may lead to tremors, restlessness, anxiety, lightheadedness, confusion, hallucinations, paranoia, depression, night-mares, insomnia, and rarely, suicidal thoughts or acts. Text Continues Below
If you notice any side effects not mentioned in this leaflet or you have concerns about the side effects you are experiencing, please inform your health care professional. For more complete information regarding levofloxacin, please refer to the full prescribing information, which may be obtained from your health care professional, pharmacist, or the Physicians Desk Reference (PDR). What about other medicines I am taking? Taking warfarin (Coumadin ® ) and LEVAQUIN ® together can further predispose you to the development of bleeding problems. If you take warfarin, be sure to tell your health care professional. Many antacids and multivitamins may interfere with the absorption of LEVAQUIN ® and may prevent it from working properly. You should take LEVAQUIN ® either 2 hours before or 2 hours after taking these products. It is important to let your health care professional know all of the med-icines you are using. Other information Take your dose of LEVAQUIN ® once a day.
Complete the course of medication even if you are feeling better. Keep this medication out of the reach of children. This information does not take the place of discussions with your doctor or health care professional about your medical condition or your treatment. OMP DIVISION ORTHO-McNEIL PHARMACEUTICAL, INC.
Raritan, New Jersey, USA 08869
U. S. Patent No. 4,382,892 and U. S. Patent No. 5,053,407 7518207 © OMP 2000 Revised October 2003 633-10-816-8 Page: << Prev | 1 | 2 | 3
|
.gif)
